Loading clinical trials...
Loading clinical trials...
The objective of the study is to collect and assess adaptive optics (AO) retinal images from human subjects in support of projects to demonstrate, advance, and enhance clinical use of AO technology.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Food and Drug Administration (FDA)
Collaborators
NCT03675412 · Glaucoma, Primary Open Angle
NCT05999006 · Glaucoma, Primary Open Angle
NCT06053307 · Glaucoma, Primary Open Angle, Distress, Emotional, and more
NCT02796560 · Glaucoma, Primary Open Angle, Ocular Hypertension
NCT01853085 · Glaucoma, Primary Open Angle, Ocular Hypertension
Food and Drug Administration
Silver Spring, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions